Search Results 1391-1400 of 10658 for total t4

  1. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE ...

  2. Immune thrombocytopenia (ITP) - Doctors and departments - Mayo Clinic

    Related. Associated Procedures. Complete blood count (CBC) · Splenectomy. Products & Services. A Book: Mayo Clinic Family Health Book · Newsletter: Mayo Clinic ...

  3. Clinical trials - Oncology (Medical)

    The overall goal of this study is to understand if adding inotuzumab ozogamicin to standard of care chemotherapy maintains or improves outcomes in High Risk ...

  4. A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) - Mayo Clinic

    The purpose of this study is to evaluate the Maximum Tolerated Dose (MTD) of pralatrexate in combination with cyclophosphamide, doxorubicin, vincristine, and ...

  5. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

    About this study. This research study is for liver transplant recipients and their respective living donors. The purpose of this study is to see if it is ...

  6. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

    Total bilirubin >1.5 × ULN with the exception of participants with the diagnosis of Gilbert's syndrome who may be eligible provided they have no other ...

  7. DISC-3405 In Participants With Polycythemia Vera - Mayo Clinic

    Complete blood count values prior to Day 1 of HCT < 45% or of HCT < 48% if followed by a phlebotomy within 2 weeks prior to baseline, white blood cells 4000 ...

  8. Hematology - Clinical trials

    Rochester, Minn. The purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.

  9. Neurosurgery - Clinical trials

    The primary objective of the study is to evaluate the Overall Survival (OS). Pagination Clinical studies. PrevPrevious Page · Go to page 22 · Go to page 33 · Go ...

  10. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    Participation eligibility · Patients must not be candidates for allogeneic hematopoietic stem cell transplant. · Patients must have complete history and physical ...